 5. Patients must have been surgically or medically castrated. If the method of castration was LHRH agonists leuprolide or goserelin or antagonists degarelix, then the patient must be willing to continue the use of LHRH agonists or antagonists. Serum testosterone must be at castrate levels 50 ngdL within 3 months prior to registration. 